The future of chemical pleurodesis: A review of novel and investigational sclerosant agents
The American Journal of the Medical Sciences · 2024-09 · 368 (3) · 175-181
DOI: 10.1016/j.amjms.2024.04.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The American Journal of the Medical Sciences, 2024-09. Verfasst von Jonathan Glatt und 1 weiteren Autor:innen. Beteiligte Einrichtung: Thomas Jefferson University Hospital, Department of Pulmonary, Allergy, and Critical Care Medicine, 834 Walnut Street, Suite 650, Philadelphia, PA 19…. Hauptthemen laut MEDLINE: Pleurodesis, Sclerosing Solutions. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Chemical pleurodesis is a technique in which an injurious and inflammatory substance is instilled into the pleural cavity to cause adhesion and fibrosis. It is commonly used in the management of recurrent malignant pleural effusions. Historically, many different types of sclerosants have been described, though only a few, including talc, the tetracycline derivatives, and anti-septic compounds such as silver nitrate and iodopovidone, have found their way into mainstream use. However, over the past several years, there has been increasing interest in alternative pleurodesis agents. In this review, we will explore future directions in the field, with an eye toward novel and investigational agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Thomas Jefferson University Hospital, Department of Pulmonary, Allergy, and Critical Care Medicine, 834 Walnut Street, Suite 650, Philadelphia, PA 19107, USA. Electronic address: jglatt4@gmail.com.
- Thomas Jefferson University Hospital, Department of Pulmonary, Allergy, and Critical Care Medicine, 834 Walnut Street, Suite 650, Philadelphia, PA 19107, USA.
Zitieren
APA
Glatt, J., & Chandar, P. (2024). The future of chemical pleurodesis: A review of novel and investigational sclerosant agents. The American Journal of the Medical Sciences, 368(3), 175-181. https://doi.org/10.1016/j.amjms.2024.04.008
Vancouver
Glatt J, Chandar P. The future of chemical pleurodesis: A review of novel and investigational sclerosant agents. The American Journal of the Medical Sciences. 2024;368(3):175-181. doi:10.1016/j.amjms.2024.04.008
BibTeX
@article{Glatt2024,
author = {Glatt, Jonathan and Chandar, Prarthna},
title = {The future of chemical pleurodesis: A review of novel and investigational sclerosant agents},
journal = {The American Journal of the Medical Sciences},
year = {2024},
volume = {368},
number = {3},
pages = {175--181},
doi = {10.1016/j.amjms.2024.04.008}
}
EUVIMED